Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

OBJECTIVES: To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. METHODS: Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondyloarthritis in the Swiss Clinical Qua...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Hebeisen, Monika, Scherer, Almut, Micheroli, Raphael, Nissen, Michael J., Tamborrini, Giorgio, Möller, Burkhard, Zufferey, Pascal, Exer, Pascale, Ciurea, Adrian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542531/
https://ncbi.nlm.nih.gov/pubmed/31145730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0216746
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak